Insulet Corporation
NASDAQ:PODDMedical - Devices
-$4.17 today
- Market cap
- $9.71B
- Beta
- 1.13
- P/E (TTM)
- 33.2
- EPS (TTM)
- $4.33
Volume 2.09M
Average 1.32M
PODD Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Insulet CorporationNASDAQ: PODD
Stock-Based Compensation · Q2 FY2026 · quarter ended Jun 2026
Stock-based compensation growth accelerates
Q2 FY2026 stock-based compensation of $19.6M rose 161.3% year over year, ahead of the +22.1% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 8.0% from the prior quarter. Over 3 fiscal years it compounded at +15.3% a year.
Context
- Stock-based compensation amounted to 2.3% of revenue in FY2025, down 1.0 pp from a year earlier.
- Stock-based compensation increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +161.3% holds above the trailing-twelve-month pace of +22.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 62.7M USD
- Year-over-year change
- -9.5%
- 4-year CAGR
- +16.2%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 62.7M | -9.5% |
| FY2024 | 2024-12-31 | 69.3M | +43.5% |
| FY2023 | 2023-12-31 | 48.3M | +18.1% |
| FY2022 | 2022-12-31 | 40.9M | +18.9% |
| FY2021 | 2021-12-31 | 34.4M | — |
Stock-Based Compensation vs competitors
How PODD compares with its peers on the latest reported figures
- PODD's LTM Jun 2026 stock-based compensation of $77.9M is the 3rd largest of the 5 companies compared; the peer median is $50.77M.
- Its year-over-year change of +22.1% is the 2nd highest of 5, against a peer median of +6.0%.
- Stock-based compensation amounts to 2.6% of revenue for PODD, versus a peer median of 12.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $162.4M | -2.3% | +8.1% | 3.3% | |
| LTM Mar 2026 | $82.55M | -21.3% | +2.8% | 8.0% | |
| LTM Jun 2026 | $77.9M | +22.1% | +15.3% | 2.6% | |
| LTM Mar 2026 | $18.99M | +142.5% | +39.0% | 17.2% | |
| LTM Mar 2026 | $10.59M | +14.3% | +5.6% | 26.0% | |
| Peer median (excluding PODD) | $50.77M | +6.0% | +6.8% | 12.6% | |
Competitors are the stored peer set for PODD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 16.8M | 4.6M | 206.3M | 418.3M | 247.1M |
| Depreciation & Amortization | 57.4M | 63.2M | 72.8M | 80.8M | 90.4M |
| Deferred Income Tax | 0 | (1M) | 500K | (136.9M) | 62.2M |
| Stock-Based Compensation | 34.4M | 40.9M | 48.3M | 69.3M | 62.7M |
| Change in Working Capital | (263.6M) | (2.5M) | (190.6M) | (17M) | (23.1M) |
| Accounts Receivables | (71.3M) | (51.8M) | (154.2M) | (10.4M) | (140.2M) |
| Inventory | (154.4M) | (49.1M) | (53.6M) | (32.4M) | (10.6M) |
| Accounts Payables | (15.6M) | (2.4M) | (11M) | 2.2M | 49.2M |
| Other Working Capital | (22.3M) | 100.8M | 28.2M | 23.6M | 78.5M |
| Other Non-Cash Items | 86.9M | 13.8M | 8.4M | 15.8M | 130M |
| Operating Cash Flow | (68.1M) | 119M | 145.7M | 430.3M | 569.3M |
| Capital Expenditures | (122.7M) | (157.3M) | (75.6M) | (124.9M) | (191.6M) |
| Acquisitions (Net) | 0 | (26M) | (3M) | 0 | 0 |
| Purchases of Investments | 0 | (7.8M) | (7.2M) | (12.2M) | 0 |
| Sales of Investments | 40M | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (31.1M) |
| Investing Cash Flow | (82.7M) | (191.1M) | (119.4M) | (146.2M) | (222.7M) |
| Debt Repayment | 49.4M | (39.8M) | (27M) | (40.6M) | (708.1M) |
| Common Stock Issued | 23.5M | 16.3M | 26.9M | 20.1M | 33.9M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (59.6M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (32.2M) | (16.8M) | (13.5M) | (7.6M) | 138.5M |
| Financing Cash Flow | 40.7M | (40.3M) | (13.6M) | (28.1M) | (595.3M) |
| Effect of Forex Changes | (5.5M) | (4.3M) | 1.8M | (6.8M) | 11.5M |
| Net Change in Cash | (115.6M) | (116.7M) | 14.5M | 249.2M | (237.3M) |
| Free Cash Flow | (190.8M) | (38.3M) | 70.1M | 305.4M | 377.7M |
Insulet Corporation
NASDAQ:PODD
Intrinsic Alpha fair value
Locked
Current Price
$139.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.